Accrued and other current liabilities consist of the following:
December 31,
2025
2024
Compensation expense
$
9,716
8,315
Clinical trial research and development services
5,335
1,236
Manufacturing and other research and development services
3,774
2,255
General and administrative services
393
342
Other
80
40
19,298
12,188
Accrued expenses and other current liabilities.
No definition available.